Welcome to LookChem.com Sign In|Join Free

CAS

  • or

58-61-7

Post Buying Request

58-61-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Adenosine / intermediate/ nucleoside/ white powder with CAS NO.58-61-7/ world Top Pharma factory vendor with most competitive price

    Cas No: 58-61-7

  • USD $ 30.0-30.0 / Metric Ton

  • 1 Metric Ton

  • 10 Metric Ton/Month

  • YUNBIO TECH CO.,LTD
  • Contact Supplier

58-61-7 Usage

Defination

Adenosine is a natural nucleotide, which is the intermediate product of metabolism, chemically 6-amino-9-beta-D-ribofuranosyl-9-H-purine. Adenosine is one of the important active components in the body, helps in cellular energy transfer by forming molecules like adenosine triphosphate (ATP) and adenosine diphosphate (ADP). It also plays a role in signaling various pathways and functions in the body by forming signally molecules like cyclic adenosine monophosphate (cAMP).

In the body

▼▲ Adenosine in the body Function Brain Promoting sleep and suppresses arousal acting as a central nervous system depressant. Heart Causing dilation of the coronary blood vessels that Improving blood circulation to the heart; Increasing the diameter of blood vessels in the peripheral organs; Decreasing heart rate Blood Broken down by adenosine deaminase. By taking medicine like Dipyridamole(inhibitor of adenosine deaminase), it can improve blood flow through the coronary blood vessels that supply the heart muscles. Kidneys, lungs and liver In the kidneys adenosine decreases renal blood flow and decrease the production of rennin from the kidneys. In the lungs it causes constriction of airways and in the liver it leads to constriction of blood vessels and increases breakdown of glycogen to form glucose.

Medical uses

Adenosine has a role in the expansion of coronary artery and myocardial contractility, is clinically applied in the treatment of angina, hypertension, cerebrovascular disorders, stroke sequelae, muscular atrophy, etc. It is also given intravenously (by IV) for treating supraventricular tachycardia and Tl myocardial imaging. It is also used for cardiac stress tests. ? Side effects: Since the half-life of this compound is less than 10 seconds, its side effects are usually transient. However, side effects are common, and include flushing, headache, chest discomfort, bronchoconstriction, and occasionally hypotension. Hepatic and renal failure and other drugs except dipyridamole seem to have little effect on the action of adenosine. ? ? Adenosine dose

Mechanism of action

Its function is realized through the activation of the adenosine receptor (A receptor). Adenosine activates G protein coupled potassium channels by binding to the A receptor which makes increasing the outflow of K+ and cell membrane hyperpolarization so as to decrease the automaticity in the atrium, sinoatrial node and atrioventricular node. It can also significantly increase the level of cGMP , prolong ERP of the atrioventricular node and slowing of atrioventricular, depress sympathetic nervous or early and delayed after depolarization induced by isoproterenol and then plays an effective role in arrhythmia. This product has not been classified in I~IV anti arrhythmia medicine. Adenosine receptor A1 receptors, which are found in cardiomyocytes and which are responsible for the inhibition of adenylyl cylase activity which lowers cyclic adenosine monophosphate (AMP) results in sinus slowing, increase in AV node conduction delay, and antagonism of the effects of catecholamines; A2 receptors, which are found in endothelial cells and vascular smooth muscle and are responsible for the enhancement of adenylyl cylase activity and increased cyclic AMP which relaxes smooth muscle. Both negative chronotropic and dromotropic effects of adenosine are cyclic AMP independent (direct action) as well cyclic AMP dependent (indirect action).

Description

Adenosine is a nucleoside composed of a molecule of adenine attached to a ribose sugar molecule (ribofuranose) moiety via a β-N9-glycosidic bond. Adenosine works in the energy transfer-as adenosine triphosphate (ATP) and adenosine diphosphate (ADP)-as well as in signal transduction as cyclic adenosine monophosphate, cAMP. It shows neuromodulatory, cytoprotective, anti-inflammatory and cardioprotective actions.

Chemical Properties

Different sources of media describe the Chemical Properties of 58-61-7 differently. You can refer to the following data:
1. Adenosine is an important nucleoside composed of adenine and ribose. White, crystalline, odorless powder, mild, saline, or bitter taste, quite soluble in hot water, practically insoluble in alcohol. Formed by isolation following hydrolysis of yeast nucleic acid.
2. White or almost white, crystalline powder.

Uses

Different sources of media describe the Uses of 58-61-7 differently. You can refer to the following data:
1. adenosine is an amino acid. Studies indicate anti-wrinkle and skinsmoothing capacities. Although little is written about its direct skin benefit, adenosine plays an important role in biochemical processes. As adenosine triphosphate (ATP) and adenosine diphosphate (ADP), it is involved in energy transfer, and as cyclic adenosine monophosphate (cAMP) in signal transduction.
2. antiarrhythmic, cardiac depressant
3. Nucleotide.

Definition

Different sources of media describe the Definition of 58-61-7 differently. You can refer to the following data:
1. ChEBI: A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta1N9-glycosidic bond.
2. adenosine: A nucleoside comprisingone adenine molecule linked to ad-ribose sugar molecule. The phosphate-ester derivatives of adenosine,AMP, ADP, and ATP, are of fundamentalbiological importance as carriersof chemical energy.

Brand name

Adenocard (Astellas); Adenoscan (Astellas).

General Description

Adenosine is a purine nucleoside and a building block of RNA and many other biomolecules such as adenosine triphosphate and nicotinamide adenine dinucleotide. In the extracellular space, ecto-5′-nucleotidase (CD73) dephosphorylates adenosine triphosphate (ATP) to produce adenosine. Adenosine has four receptors namely A1R, A2AR A2BR and A3R. Adenosine plays a key role in the osteogenic differentiation. A1R induces osteoclast differentiation and A2AR induces osteoblast differentiation.

Biological Activity

Neurotransmitter that acts as the preferred endogenous agonist at all adenosine receptor subtypes.

Biochem/physiol Actions

Endogenous neurotransmitter at adenosine receptors. Cardioprotective effects may relate to activation of A1 adenosine receptors. The antiplatelet and anti?inflammatory actions of adenosine appear to be mediated via the A2 adenosine receptor. In contrast, adenosine appears to be a pro-inflammatory mediator in asthma and chronic obstructive pulmonary disease (COPD).

Clinical Use

Adenosine (Adenocard) is an endogenous nucleoside that is a product of the metabolism of adenosine triphosphate. It is used for the rapid termination of supraventricular arrhythmias following rapid bolus dosing. Adenosine is approved for the acute management and termination of supraventricular tachyarrhythmias, including A-V nodal reentrant tachycardia and A-V reciprocating tachycardia. Adenosine may be helpful in the diagnosis of atrial flutter.

Side effects

Adverse reactions to the administration of adenosine are fairly common; however, the short half-life of the drug limits the duration of such events.The most common adverse effects are flushing, chest pain, and dyspnea. Adenosine may induce profound bronchospasm in patients with known reactive airway disease. The mechanism for bronchospasm is unclear, and the effect may last for up to 30 minutes despite the short half-life of the drug.

Drug interactions

Metabolism of adenosine is slowed by dipyridamole, indicating that in patients stabilized on dipyridamole the therapeutically effective dose of adenosine may have to be increased. Methylxanthines antagonize the effects of adenosine via blockade of the adenosine receptors.

Metabolism

It is impossible to study adenosine in classical pharmacokinetic studies, since it is present in various forms in all the cells of the body. An efficient salvage and recycling system exists in the body, primarily in erythrocytes and blood vessel endothelial cells. The halflife in vitro is estimated to be less than 10 seconds, and may be even shorter in vivo.

Purification Methods

Crystallise adenosine from distilled water and dry it at 110o. It has been purified via the picrate, where ethanolic picric acid is added to adenosine and the picrate is filtered off and recrystallised from EtOH. It has m 180-185o(dec). Adenosine is recovered by dissolving 0.4g of the picrate in 80mL of hot H2O, treated with a small quantity of Dowex 1 anion exchange resin in the chloride form, and the resin is filtered off. The filtrate is treated with more resin and filtered again. One equivalent of aqueous NaOH is added to the colourless filtrate which is evaporated to 4mL and cooled to give 0.176g of adenosine m 236o. [Davoll et al. J Chem Soc 967 1948, Davoll & Lowy J Am Chem Soc 73 1650 1951, Beilstein 26 III/IV 3598.]

Precautions

Patients with second- or third-degree A-V block should not receive adenosine. As indicated previously, the use of adenosine in asthmatic patients may exacerbate the asthmatic symptoms.

Check Digit Verification of cas no

The CAS Registry Mumber 58-61-7 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 8 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 58-61:
(4*5)+(3*8)+(2*6)+(1*1)=57
57 % 10 = 7
So 58-61-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6+,7+,10+/m1/s1

58-61-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A0152)  Adenosine  >99.0%(HPLC)(T)

  • 58-61-7

  • 5g

  • 190.00CNY

  • Detail
  • TCI America

  • (A0152)  Adenosine  >99.0%(HPLC)(T)

  • 58-61-7

  • 25g

  • 650.00CNY

  • Detail
  • TCI America

  • (A0152)  Adenosine  >99.0%(HPLC)(T)

  • 58-61-7

  • 100g

  • 2,200.00CNY

  • Detail
  • Alfa Aesar

  • (A10781)  Adenosine, 99%   

  • 58-61-7

  • 10g

  • 300.0CNY

  • Detail
  • Alfa Aesar

  • (A10781)  Adenosine, 99%   

  • 58-61-7

  • 50g

  • 1006.0CNY

  • Detail
  • Alfa Aesar

  • (A10781)  Adenosine, 99%   

  • 58-61-7

  • 250g

  • 4410.0CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1138)  Adenosine  pharmaceutical secondary standard; traceable to USP and PhEur

  • 58-61-7

  • PHR1138-1G

  • 732.19CNY

  • Detail
  • Sigma-Aldrich

  • (A0230200)  Adenosine  European Pharmacopoeia (EP) Reference Standard

  • 58-61-7

  • A0230200

  • 1,880.19CNY

  • Detail
  • USP

  • (1012123)  Adenosine  United States Pharmacopeia (USP) Reference Standard

  • 58-61-7

  • 1012123-200MG

  • 4,588.74CNY

  • Detail
  • Sigma

  • (A9251)  Adenosine  ≥99%

  • 58-61-7

  • A9251-1G

  • 188.37CNY

  • Detail
  • Sigma

  • (A9251)  Adenosine  ≥99%

  • 58-61-7

  • A9251-5G

  • 349.83CNY

  • Detail
  • Sigma

  • (A9251)  Adenosine  ≥99%

  • 58-61-7

  • A9251-25G

  • 969.93CNY

  • Detail

58-61-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name adenosine

1.2 Other means of identification

Product number -
Other names Adenine riboside

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58-61-7 SDS

58-61-7Synthetic route

(2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-4-(benzyloxy)-5-(hydroxymethyl) tetrahydrofuran-3-ol
35638-82-5

(2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-4-(benzyloxy)-5-(hydroxymethyl) tetrahydrofuran-3-ol

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol at 50℃;100%
triacetyladenosine
7387-57-7

triacetyladenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With lipase A from Aspergillus niger In aq. phosphate buffer; acetonitrile at 25℃; for 0.5h; pH=7; Enzymatic reaction;99%
With ammonia at 25℃;83%
With methanol; ammonia
3',5'-O-(1,1,3,3-tetra-isopropyldisiloxane-1,3-diyl)adenosine
69304-45-6

3',5'-O-(1,1,3,3-tetra-isopropyldisiloxane-1,3-diyl)adenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonium fluoride In methanol at 60℃; for 3h;99%
With ammonium fluoride In methanol at 60℃; for 3h; other silyl ethers;99%
N6-<2-(4-nitrophenyl)ethoxycarbonyl>adenosine
88121-73-7

N6-<2-(4-nitrophenyl)ethoxycarbonyl>adenosine

methylamine
74-89-5

methylamine

A

2-(4-nitrophenyl)ethyl N-methylcarbamate

2-(4-nitrophenyl)ethyl N-methylcarbamate

B

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
In 1,4-dioxane for 1.5h; Product distribution; Mechanism; Ambient temperature;A 93%
B 99%
5'-O-(p-methoxyphenyldiphenylmethyl)adenosine
51600-11-4

5'-O-(p-methoxyphenyldiphenylmethyl)adenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate; silica gel In dichloromethane at 25℃; for 0.1h; detritylation;98%
With hydrogenchloride In water; acetonitrile at 60℃; for 0.25h; pH=Ca. 1; Inert atmosphere;63 mg
N6-methyladenosine
1867-73-8

N6-methyladenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With benzophenone; Selectfluor In water; acetonitrile for 5h; Reagent/catalyst; Inert atmosphere; UV-irradiation;97%
With Selectfluor; riboflavin In water; acetonitrile at 37℃; under 760.051 Torr; for 2h; Reagent/catalyst; Inert atmosphere; Irradiation;86%
With manganese(IV) oxide; C17H20N4O9P(1-)*Na(1+); oxygen In water; acetonitrile at 20℃; under 760.051 Torr; for 7h; Mechanism; Kinetics; Reagent/catalyst; Irradiation; chemoselective reaction;79%
With dihydrogen peroxide; ammonium bicarbonate at 37℃; for 24h;
5'-O-(triphenylmethyl)adenosine
18048-85-6

5'-O-(triphenylmethyl)adenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate; silica gel In dichloromethane at 25℃; for 1.5h; detritylation;95%
With cerium(IV) triflate; water In acetonitrile at 25℃; for 1.5h;88%
With chlorine In chloroform at 4℃; for 0.5h;85%
With sulfuric acid; water; silica gel In acetonitrile at 25℃; for 0.283333h;82%
With trifluoroacetic acid In water; acetonitrile at 0 - 20℃; for 12h;36 mg
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((4-methoxybenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
23666-24-2

(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((4-methoxybenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonium peroxydisulfate; phosphate buffer at 80℃; for 2h;95%
5'-O-dimethoxytrityladenosine
57018-82-3, 81352-25-2

5'-O-dimethoxytrityladenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With K 10 clay In methanol; water for 20h; Ambient temperature;95%
With cerium(IV) triflate; water In acetonitrile at 25℃; for 0.75h;95%
With 1,1,1,3',3',3'-hexafluoro-propanol for 1h; Ambient temperature;87 % Turnov.
Multi-step reaction with 6 steps
1: Et3N; DMAP / CH2Cl2
2: dichloroacetic acid; pyrrole / CH2Cl2
3: 87 percent / 2,4,6-triisopropylbenzenesulfonyl chloride; 3-nitro-1,2,4-1H-triazole; pyridine / 1 h / 20 °C
4: Me3SiCl / acetonitrile / 6 h / 60 °C
5: 0.060 g / aq. NH3 / acetonitrile / 0.08 h / 20 °C
6: CD3CO2D; D2O / 23 °C
View Scheme
8-bromoadenosine
2946-39-6

8-bromoadenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With tris-(trimethylsilyl)silane; 2-hydroxyethanethiol In water at 100℃; for 4h;94%
With potassium fluoride; N,O-bis-(trimethylsilyl)-acetamide; perhydrodibenzo-18-crown-6 In acetonitrile for 96h; Heating;36%
With tris-(trimethylsilyl)silane; 2-hydroxyethanethiol; 1,1'-azobis(1-cyanocyclohexanenitrile); triethylamine In water at 100℃; for 1h;94 % Turnov.
Multi-step reaction with 2 steps
1.1: H2SO4; NaNO2; KBr / 3 h / -15 - 20 °C
1.2: H2O / 65 °C
1.3: 0.14 g / aq. NaOH / dimethylsulfoxide / 5 h
2.1: UV-irradiation
View Scheme
Multi-step reaction with 3 steps
1: pyridine / 0.5 h
2: sodium naphthalenide / tetrahydrofuran / -60 °C
3: aq. NH3 / methanol / 0.5 h
View Scheme
5'-(O-tert-butyldimethylsilyl)adenosine
69530-93-4

5'-(O-tert-butyldimethylsilyl)adenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With K 10 clay In methanol; water at 75℃; for 10h;93%
(2R,3R,4S,5R)-2-(6-(tritylamino)-9H-purin-9-yl)-5-((trityloxy)methyl)tetrahydrofuran-3,4-diol
31085-55-9

(2R,3R,4S,5R)-2-(6-(tritylamino)-9H-purin-9-yl)-5-((trityloxy)methyl)tetrahydrofuran-3,4-diol

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate; silica gel In dichloromethane at 25℃; for 2h; detritylation;92%
adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With Dimethylphenylsilane In dimethyl sulfoxide at 20℃; for 24h; Inert atmosphere;91%
With GLUTATHIONE for 144h; Product distribution; Mechanism; Ambient temperature; Irradiation; pH 7.0 (phosphate buffer);60%
5'-(anthraquinon-2-ylmethoxycarbonyl)adenosine
350498-61-2

5'-(anthraquinon-2-ylmethoxycarbonyl)adenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With KMOPS buffer In tetrahydrofuran Photolysis;91%
[9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-yl]-carbamic acid 2-nitro-benzyl ester
473910-22-4

[9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-yl]-carbamic acid 2-nitro-benzyl ester

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
In 1,4-dioxane; water for 1.5h; UV-irradiation;90%
N6-Benzyladenosine
4294-16-0

N6-Benzyladenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonium peroxydisulfate; phosphate buffer at 80℃; for 2h;89%
Conditions
ConditionsYield
With Enterobacter gergoviae CECT 875 in agarose In phosphate buffer at 60℃; for 3h; pH=7.0; Enzymatic reaction;89%
With Citrobacter koseri In aq. phosphate buffer at 60℃; for 1.5h; pH=7; Microbiological reaction;62%
With Escherichia coli BL21 In phosphate buffer at 60℃; for 1h; pH=7; Enzymatic reaction;
9-(2R,3R,4R,5R)-3,4-bis((tert-butyldiphenylsilyl)oxy)-5-((((tert-butyldiphenylsilyl)oxy)methyl)oxolan-2-yl)-6-chloro-9H-purine

9-(2R,3R,4R,5R)-3,4-bis((tert-butyldiphenylsilyl)oxy)-5-((((tert-butyldiphenylsilyl)oxy)methyl)oxolan-2-yl)-6-chloro-9H-purine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonia at 120 - 130℃; for 24h;87.2%
Conditions
ConditionsYield
With Enterobacter gergoviae CECT 875 in agarose In phosphate buffer at 60℃; for 2h; pH=7.0; Enzymatic reaction;84%
With Escherichia coli BL21 In phosphate buffer at 60℃; pH=7; Enzymatic reaction;
2'-O-tosyladenosine
42776-78-3

2'-O-tosyladenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With sodium naphthalenide In tetrahydrofuran at -78℃;82%
C41H37N5O8Si

C41H37N5O8Si

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonia In methanol at 24℃; for 16h;80.9%
9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)purine-6-sulfonamide
123002-33-5

9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)purine-6-sulfonamide

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonia In methanol at -5℃; for 5h;80%
2',3'-isopropylidene adenosine
362-75-4

2',3'-isopropylidene adenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With K 10 clay In methanol; water at 75℃; for 55h;80%
With water at 150℃; for 0.5h; microwave irradiation;32%
Multi-step reaction with 3 steps
1.1: DMAP / CH2Cl2 / 17 h / 20 °C
1.2: CH2Cl2 / 48 h / 45 °C
2.1: 98 percent / TFA / tetrahydrofuran; H2O / 13 h
3.1: 91 percent / KMOPS buffer / tetrahydrofuran / Photolysis
View Scheme
With erbium(III) triflate In water at 120℃; for 0.5h; Microwave irradiation;88 % Chromat.
2-hydrazinoadenosine
15763-11-8

2-hydrazinoadenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With water; oxygen; copper(II) sulfate at 80℃; for 6h; Green chemistry;79%
With potassium trimethylsilonate In water at 70℃; for 48h; Temperature; Green chemistry;89 %Spectr.
8-mercaptoadenosine
3001-45-4

8-mercaptoadenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With nitric acid In water at 50℃; for 1h;79%
N,N-dimethyladenosine
2620-62-4

N,N-dimethyladenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With Selectfluor; riboflavin In water; acetonitrile for 7h; Inert atmosphere; UV-irradiation;78%
N,N-dimethyladenosine
2620-62-4

N,N-dimethyladenosine

A

N6-methyladenosine
1867-73-8

N6-methyladenosine

B

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With Selectfluor; riboflavin In water; acetonitrile at 37℃; under 760.051 Torr; for 7h; Inert atmosphere; Irradiation;A 17%
B 78%
5'-O-acetyladenosine
2140-25-2

5'-O-acetyladenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With methanol; water; triethylamine at 71℃; Microwave irradiation;75%
N6,2',3',5'-tetra-O-benzoyladenosine
6984-53-8

N6,2',3',5'-tetra-O-benzoyladenosine

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With ammonia In methanol at 50℃; for 16h;74%
With ammonia In methanol at 24℃; for 72h;62.7%
With ammonia In methanol Substitution;
acetic anhydride
108-24-7

acetic anhydride

adenosine
58-61-7

adenosine

6-N-2',3',5'-tri-O-tetraacetyladenosine
7387-58-8, 80007-24-5

6-N-2',3',5'-tri-O-tetraacetyladenosine

Conditions
ConditionsYield
With pyridine at 20℃;100%
In pyridine for 8h; Heating;55%
With sodium acetate
Stage #1: acetic anhydride; adenosine With pyridine at 20 - 60℃;
Stage #2: With 1H-imidazole; methanol at 20℃;
2.73 g
acetone
67-64-1

acetone

adenosine
58-61-7

adenosine

2',3'-isopropylidene adenosine
362-75-4

2',3'-isopropylidene adenosine

Conditions
ConditionsYield
With toluene-4-sulfonic acid; orthoformic acid triethyl ester at 20℃;100%
With p-toluenesulfonic acid monohydrate for 3h; Inert atmosphere;100%
With toluene-4-sulfonic acid at 20℃; for 1h; Inert atmosphere;99%
adenosine
58-61-7

adenosine

Inosine
58-63-9

Inosine

Conditions
ConditionsYield
With phosphate buffer at 25℃; for 0.666667h; AMP deaminase from Aspergillus sp.;100%
With calf intestine adenosine deaminase In water at 20℃; for 24h; Enzymatic reaction;100%
With water; adenosine deaminase for 16h; Enzymatic reaction;100%
C12H13N7
406945-71-9

C12H13N7

adenosine
58-61-7

adenosine

(2R,3R,4S,5R)-2-(6-Amino-purin-9-yl)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-3-olate1-(2-amino-9H-purin-6-yl)-4-dimethylamino-pyridinium;

(2R,3R,4S,5R)-2-(6-Amino-purin-9-yl)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-3-olate1-(2-amino-9H-purin-6-yl)-4-dimethylamino-pyridinium;

Conditions
ConditionsYield
In water-d2100%
adenosine
58-61-7

adenosine

5'-iodo-5'-deoxyadenosine
4099-81-4

5'-iodo-5'-deoxyadenosine

Conditions
ConditionsYield
With pyridine; iodine; triphenylphosphine at 20℃; for 2h;100%
With pyridine; iodine; triphenylphosphine for 2h;100%
With pyridine; iodine; triphenylphosphine at 0 - 20℃; for 2h;90%
3C5H13NO*3C9H9NO3

3C5H13NO*3C9H9NO3

adenosine
58-61-7

adenosine

3C5H13NO*3C9H9NO3*C10H13N5O4

3C5H13NO*3C9H9NO3*C10H13N5O4

Conditions
ConditionsYield
at 20℃; for 3h;100%
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

acetone
67-64-1

acetone

adenosine
58-61-7

adenosine

2',3'-isopropylidene adenosine
362-75-4

2',3'-isopropylidene adenosine

Conditions
ConditionsYield
With toluene-4-sulfonic acid at 20℃; for 72h; Inert atmosphere;100%
Stage #1: 2,2-dimethoxy-propane; acetone; adenosine With d-10-camphorsulphonic acid for 3h;
Stage #2: With sodium hydrogencarbonate In water; ethyl acetate
N,N-dibutylformamide dimethyl acetal
19449-30-0

N,N-dibutylformamide dimethyl acetal

adenosine
58-61-7

adenosine

6-N-(N,N-dibutylformamidine)adenosine
1228304-61-7

6-N-(N,N-dibutylformamidine)adenosine

Conditions
ConditionsYield
In methanol at 20℃; for 12h;100%
4-oxopentanoic acid ethyl ester
539-88-8

4-oxopentanoic acid ethyl ester

adenosine
58-61-7

adenosine

ethyl 3-[4-hydroxymethyl-2-methyl-6-(6-oxo-1,6-dihydropurin-9-yl)tetrahydrofuro[3,4-d][1,3]dioxol-2-yl]propionate

ethyl 3-[4-hydroxymethyl-2-methyl-6-(6-oxo-1,6-dihydropurin-9-yl)tetrahydrofuro[3,4-d][1,3]dioxol-2-yl]propionate

Conditions
ConditionsYield
Stage #1: 4-oxopentanoic acid ethyl ester; adenosine With hydrogenchloride; orthoformic acid triethyl ester In 1,4-dioxane; N,N-dimethyl-formamide at 20℃;
Stage #2: With calf intestine adenosine deaminase In water; glycerol at 20℃; for 72h; Enzymatic reaction;
100%
tert-butylchlorodiphenylsilane
58479-61-1

tert-butylchlorodiphenylsilane

adenosine
58-61-7

adenosine

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((tert-butyldiphenylsilyloxy)methyl)tetrahydrofuran-3,4-diol
119898-65-6

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((tert-butyldiphenylsilyloxy)methyl)tetrahydrofuran-3,4-diol

Conditions
ConditionsYield
With pyridine; dmap at 20℃; for 72h; Inert atmosphere;99%
With dmap In pyridine at 20℃; for 40h;98.9%
In pyridine for 24h; Ambient temperature;80%
N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

adenosine
58-61-7

adenosine

N6-(N,N'-Dimethylaminomethylene)adenosine
17331-15-6

N6-(N,N'-Dimethylaminomethylene)adenosine

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 60℃; for 1h;99%
In N,N-dimethyl-formamide at 40℃; for 1h;66%
adenosine
58-61-7

adenosine

[2,8-2H2]-adenosine
82845-88-3

[2,8-2H2]-adenosine

Conditions
ConditionsYield
With hydrogen; water-d2; palladium on activated charcoal at 110℃; for 24h;99%
With water-d2; palladium on activated charcoal; hydrogen at 110℃; for 24h;99%
With hydrogen; water-d2; palladium 10% on activated carbon at 110 - 140℃; for 48h; Product distribution / selectivity; Heating / reflux;74%
With deuterium In water-d2 at 55℃; under 1500.15 Torr; for 36h; Glovebox;
1-Iodonaphthalene
90-14-2

1-Iodonaphthalene

adenosine
58-61-7

adenosine

8-1-naphthyladenosine
1037298-62-6

8-1-naphthyladenosine

Conditions
ConditionsYield
With copper(l) iodide; caesium carbonate; palladium diacetate In N,N-dimethyl-formamide at 120℃; for 13h;99%
diphenyltin(IV) dichloride
1135-99-5

diphenyltin(IV) dichloride

adenosine
58-61-7

adenosine

A

[SnCl3(C6H5)(C5H2N4(C4H4O(OH)2CH2OH)NH2)2]

[SnCl3(C6H5)(C5H2N4(C4H4O(OH)2CH2OH)NH2)2]

B

triphenyltin chloride
639-58-7

triphenyltin chloride

Conditions
ConditionsYield
In methanol refluxing under N2 for 48 h;; removal of volatiles by distn.; residue was washed with ether in portions; ether extract afforded SnClPh3; elem. anal.;;A 99%
B n/a
Rh2(OCOCH3)2(NHCOCF3)2
499769-85-6

Rh2(OCOCH3)2(NHCOCF3)2

water
7732-18-5

water

adenosine
58-61-7

adenosine

[Rh2(acetato)2(trifluoroacetamido)2(adenosine)]*2H2O

[Rh2(acetato)2(trifluoroacetamido)2(adenosine)]*2H2O

Conditions
ConditionsYield
In methanol; water addn. of a hot (60°C) soln. of ligand in methanol to a soln. of rhodium complex in methanol at 60°C, standing at room temp.; filtration, air drying; elem. anal.;99%
tetrakis(μ-acetato)-dirhodium(II)*dimethanol

tetrakis(μ-acetato)-dirhodium(II)*dimethanol

adenosine
58-61-7

adenosine

tetrakis-μ-acetato-dirhodium(II) adenosine adduct

tetrakis-μ-acetato-dirhodium(II) adenosine adduct

Conditions
ConditionsYield
In methanol; water addn. of a hot (60°C) soln. of ligand in methanol to a soln. of rhodium complex in methanol at 60°C, standing at room temp.; filtration, air drying; elem. anal.;99%
methanol
67-56-1

methanol

tetrakis(μ-trifluoroacetamidato)dirhodium(II)
81988-04-7

tetrakis(μ-trifluoroacetamidato)dirhodium(II)

adenosine
58-61-7

adenosine

[Rh2(trifluoroacetamido)4(adenosine)]*2CH3OH

[Rh2(trifluoroacetamido)4(adenosine)]*2CH3OH

Conditions
ConditionsYield
In methanol; water addn. of a hot (60°C) soln. of ligand in methanol to a soln. of rhodium complex in methanol at 60°C, standing at room temp.; filtration, air drying; elem. anal.;99%
benzoyl chloride
98-88-4

benzoyl chloride

adenosine
58-61-7

adenosine

N6,N6,2'-O,3'-O-tetrabenzoyladenosine
58463-04-0

N6,N6,2'-O,3'-O-tetrabenzoyladenosine

Conditions
ConditionsYield
Stage #1: adenosine With pyridine; tert-butyldimethylsilyl chloride at 0 - 20℃; for 9h;
Stage #2: benzoyl chloride at 0 - 20℃;
Stage #3: With trifluoroacetic acid In tetrahydrofuran; water at 20℃; for 3h; Time;
99%
ortho-toluoyl chloride
933-88-0

ortho-toluoyl chloride

adenosine
58-61-7

adenosine

N6,N6,2',3',5'-penta-O-toluoyladenosine
104557-13-3

N6,N6,2',3',5'-penta-O-toluoyladenosine

Conditions
ConditionsYield
In pyridine for 4h; Ambient temperature;98%
benzoic acid anhydride
93-97-0

benzoic acid anhydride

adenosine
58-61-7

adenosine

2',3',5'-tri-O-benzoyladenosine
51549-15-6

2',3',5'-tri-O-benzoyladenosine

Conditions
ConditionsYield
With pyridine; dmap for 2h; Ambient temperature;98%
With dmap In various solvent(s) at 50℃; for 2.5h;92%
adenosine
58-61-7

adenosine

2',3'-dehydroadenosine
2627-64-7, 4336-89-4, 40110-98-3

2',3'-dehydroadenosine

Conditions
ConditionsYield
With acetoxyisobutyryl bromide In water; acetonitrile at 20℃; for 1h;98%
Ν,Ν-diisobutylformamide dimethylacetal
50746-36-6

Ν,Ν-diisobutylformamide dimethylacetal

adenosine
58-61-7

adenosine

N6-diisobutylaminomethyleneadenosine

N6-diisobutylaminomethyleneadenosine

Conditions
ConditionsYield
In methanol97.4%
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

adenosine
58-61-7

adenosine

2',3'-isopropylidene adenosine
362-75-4

2',3'-isopropylidene adenosine

Conditions
ConditionsYield
With methanesulfonic acid In N,N-dimethyl-formamide; acetone at 60℃; for 6h; Inert atmosphere;96.3%
With Amberlyst 15H+ resin In DMF (N,N-dimethyl-formamide) at 55℃; for 3h;95%
With Amberlyst 15H+ resin In N,N-dimethyl-formamide at 55℃; for 3h;95%
benzoyl chloride
98-88-4

benzoyl chloride

adenosine
58-61-7

adenosine

N6,N6,2',3',5'-pentabenzoyl-β-D-adenosine
62374-23-6

N6,N6,2',3',5'-pentabenzoyl-β-D-adenosine

Conditions
ConditionsYield
With pyridine at 65℃; for 4h;96.2%
In pyridine for 20h;94%
With pyridine at 80℃; for 4h;82%

58-61-7Relevant articles and documents

Escherichia coli Bl21: A useful biocatalyst for the synthesis purine nucleosides

Rogert,Martinez,Porro,Lewkowicz,Iribarren

, p. 535 - 536 (2000)

E. coli BL21 cells were able to synthesize several purine nucleosides from pyrimidine ones. Kinetics and yields of this reaction showed a strong dependence on pH, temperature, reagent concentrations and weight of wet cell paste. Yields over 90% were reached in the synthesis of adenosine.

-

Carter

, p. 1466,1469 (1950)

-

SYNTHESIS OF 2'-5',3'-5' LINKED TRIADENYLATES

Hayakawa, Y.,Nobori, T.,Noyori, R.,Imai, J.

, p. 2623 - 2626 (1987)

2'-5',3'-5' Linked triadenylates have been synthesized by direct bisadenylylation of adenosine 2' and 3' hydroxyls with an adenosine 5'-phosphorochloridite followed by oxidation.

Efficient cleavage of adenylyl(3'-5')adenosine by triethylenetetraminecobalt(III)

Matsumoto,Komiyama

, p. 1050 - 1051 (1990)

-

-

Gulland,Holiday

, p. 765,766,768 (1936)

-

Simultaneous High-Resolution Detection of Bioenergetic Molecules using Biomimetic-Receptor Nanopore

Su, Zhuoqun,Wei, Yongfeng,Kang, Xiao-Feng

, p. 15255 - 15259 (2019)

A novel artificial receptor, heptakis-[6-deoxy-6-(2-hydroxy-3-trimethylammonion-propyl) amino]-beta-cyclomaltoheptaose, with similar functions of mitochondrial ADP/ATP carrier protein, was synthesized and harbored in the engineered α-HL (M113R)7 nanopore, forming a single-molecule biosensor for sensing bioenergetic molecules and their transformations. The strategy significantly elevates both selectivity and signal-to-noise, which enables simultaneous recognition and detection of ATP, ADP, and AMP by real-time single-molecule measurement.

New nucleoside-based polymeric supports for the solid phase synthesis of ribose-modified nucleoside analogues

De Napoli, Lorenzo,Di Fabio, Giovanni,D'Onofrio, Jennifer,Montesarchio, Daniela

, p. 1975 - 1979 (2004)

New solid supports, linking protected pyrimidine and purine nucleoside derivatives through the nucleobase, have been prepared. The support, incorporating a suitable derivative of 2′-azido, 2′-deoxyuridine, allowed the simple and efficient solid-phase synthesis of ribose-modified nucleoside and nucleic acid analogues, particularly of aminoacyl derivatives of 2′-deoxy, 2′-amino-uridine, following methodologies well established in peptide and oligonucleotide chemistry.

Utilization of real-time electrospray ionization mass spectrometry to gain further insight into the course of nucleotide degradation by intestinal alkaline phosphatase

Kaufmann, Christine M.,Grassmann, Johanna,Treutter, Dieter,Letzel, Thomas

, p. 869 - 878 (2014)

RATIONALE Related with its ability to degrade nucleotides, intestinal alkaline phosphatase (iAP) is an important participant in intestinal pH regulation and inflammatory processes. However, its activity has been investigated mainly by using artificial non-nucleotide substrates to enable the utilization of conventional colorimetric methods. To capture the degradation of the physiological nucleotide substrate of the enzyme along with arising intermediates and the final product, the enzymatic assay was adapted to mass spectrometric detection. Therewith, the drawbacks associated with colorimetric methods could be overcome. METHODS Enzymatic activity was comparatively investigated with a conventional colorimetric malachite green method and a single quadrupole mass spectrometer with an electrospray ionization source using the physiological nucleotide substrates ATP, ADP or AMP and three different pH-values in either methodological approach. By this means the enzymatic activity was assessed on the one hand by detecting the phosphate release spectrometrically at defined time points of enzymatic reaction or on the other by continuous monitoring with mass spectrometric detection. RESULTS Adaption of the enzymatic assay to mass spectrometric detection disclosed the entire course of all reaction components - substrate, intermediates and product - resulting from the degradation of substrate, thereby pointing out a stepwise removal of phosphate groups. By calculating enzymatic substrate conversion rates a distinctively slower degradation of AMP compared to ADP or ATP was revealed together with the finding of a substrate competition between ATP and ADP at alkaline pH. CONCLUSIONS The comparison of colorimetric and mass spectrometric methods to elucidate enzyme kinetics and specificity clearly underlines the advantages of mass spectrometric detection for the investigation of complex multi-component enzymatic assays. The entire course of enzymatic substrate degradation was revealed with different nucleotide substrates, thus allowing a specific monitoring of intestinal alkaline phosphatase activity. Copyright 2014 John Wiley & Sons, Ltd. Copyright

Hydrolysis of an RNA dinucleoside monophosphate by neomycin B

Kirk, Sarah R.,Tor, Yitzhak

, p. 147 - 148 (1998)

Neomycin B is shown to accelerate the phosphodiester hydrolysis of adenylyl(3′-5′)adenosine (ApA) more effectively than a simple unstructured diamine.

H-Bond activated glycosylation of nucleobases: Implications for prebiotic nucleoside synthesis

Singh, Palwinder,Singh, Amrinder,Kaur, Jagroop,Holzer, Wolfgang

, p. 3158 - 3161 (2014)

Glycosylation of nucleobases is achieved by heating metal free aqueous solution of nucleobase and sugar. It seems that abstraction of N 9/N1 H by C1′-OH promotes N 9/N1(nucleobase)-C1′ (sug

Prebiotic stereoselective synthesis of purine and noncanonical pyrimidine nucleotide from nucleobases and phosphorylated carbohydrates

Kim, Hyo-Joong,Benner, Steven A.

, p. 11315 - 11320 (2017)

According to a current RNA first model for the origin of life, RNA emerged in some form on early Earth to become the first biopolymer to support Darwinism here. Threose nucleic acid (TNA) and other polyelectrolytes are also considered as the possible first Darwinian biopolymer(s). This model is being developed by research pursuing a Discontinuous Synthesis Model (DSM) for the formation of RNA and/or TNA from precursor molecules that might have been available on early Earth from prebiotic reactions, with the goal of making the model less discontinuous. In general, this is done by examining the reactivity of isolated products from proposed steps that generate those products, with increasing complexity of the reaction mixtures in the proposed mineralogical environments. Here, we report that adenine, diaminopurine, and hypoxanthine nucleoside phosphates and a noncanonical pyrimidine nucleoside (zebularine) phosphate can be formed from the direct coupling reaction of cyclic carbohydrate phosphates with the free nucleobases. The reaction is stereoselective, giving only the β-anomer of the nucleotides within detectable limits. For purines, the coupling is also regioselective, giving the N-9 nucleotide for adenine as a major product. In the DSM, phosphorylated carbohydrates are presumed to have been available via reactions explored previously [Krishnamurthy R, Guntha S, Eschenmoser A (2000) Angew Chem Int Ed 39:2281-2285], while nucleobases are presumed to have been available from hydrogen cyanide and other nitrogenous species formed in Earth's primitive atmosphere.

S-adenosyl-L-methionine:Hydroxide adenosyltransferase: A SAM enzyme

Deng, Hai,Botting, Catherine H.,Hamilton, John T. G.,Russell, Rupert J. M.,O'Hagan, David

, p. 5357 - 5361 (2008)

(Chemical Equation Presented) Not so DUF: A DUF62 enzyme from the archaeon Pyrococcus horikoshii OT3 converts S-adenosyl-L-methionine (SAM) into adenosine through the nucleophilic attack of a hydroxide ion derived from water (see picture of the active site). The highly conserved nature of Asp68, Arg75, and His127 throughout the DUF62 protein superfamily suggests the wide-spread distribution of this novel catalytic activity in microorganisms. DUF = domain of unknown function.

Prebiotic Photochemical Coproduction of Purine Ribo- And Deoxyribonucleosides

Xu, Jianfeng,Green, Nicholas J.,Russell, David A.,Liu, Ziwei,Sutherland, John D.

supporting information, p. 14482 - 14486 (2021/09/18)

The hypothesis that life on Earth may have started with a heterogeneous nucleic acid genetic system including both RNA and DNA has attracted broad interest. The recent finding that two RNA subunits (cytidine, C, and uridine, U) and two DNA subunits (deoxyadenosine, dA, and deoxyinosine, dI) can be coproduced in the same reaction network, compatible with a consistent geological scenario, supports this theory. However, a prebiotically plausible synthesis of the missing units (purine ribonucleosides and pyrimidine deoxyribonucleosides) in a unified reaction network remains elusive. Herein, we disclose a strictly stereoselective and furanosyl-selective synthesis of purine ribonucleosides (adenosine, A, and inosine, I) and purine deoxynucleosides (dA and dI), alongside one another, via a key photochemical reaction of thioanhydroadenosine with sulfite in alkaline solution (pH 8-10). Mechanistic studies suggest an unexpected recombination of sulfite and nucleoside alkyl radicals underpins the formation of the ribo C2′-O bond. The coproduction of A, I, dA, and dI from a common intermediate, and under conditions likely to have prevailed in at least some primordial locales, is suggestive of the potential coexistence of RNA and DNA building blocks at the dawn of life.

Meteorite-catalyzed intermoleculartrans-glycosylation produces nucleosides under proton beam irradiation

Bizzarri, Bruno Mattia,Fanelli, Angelica,Kapralov, Michail,Krasavin, Eugene,Saladino, Raffaele

, p. 19258 - 19264 (2021/06/03)

Di-glycosylated adenines act as glycosyl donors in the intermoleculartrans-glycosylation of pyrimidine nucleobases under proton beam irradiation conditions. Formamide and chondrite meteorite NWA 1465 increased the yield and the selectivity of the reaction

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 58-61-7